Literature DB >> 17223186

Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS-/-) before and after pentylenetetrazole kindling.

Grazia De Luca1, Rosa Maria Di Giorgio, Salvatore Macaione, Pina Rita Calpona, Eugenio Donato Di Paola, Nicola Costa, Salvatore Cuzzocrea, Rita Citraro, Emilio Russo, Giovambattista De Sarro.   

Abstract

Inducible nitric oxide synthase knock-out (iNOS(-/-)) mice are valid models of investigation for the role of iNOS in patho-physiological conditions. There are no available data concerning neuroactive amino acid levels of iNOS(-/-) mice and their behaviour in response to pentylenetetrazole (PTZ). We found no significant differences in the convulsive dose 50 (CD(50)) between iNOS(-/-) and control (iNOS(+/+)) mice, however, iNOS(-/-) mice reach the kindled status more slowly than control, suggesting that in basal condition the GABA-benzodiazepine inhibitory inputs are unaltered by iNOS mutation. Clear differences between iNOS(+/+) and iNOS(-/-) mice amino acid concentrations were evident both in basal conditions and after kindling. Our results show that aspartate was significantly lower in all brain areas studied except the brain stem whereas glutamate and glutamine were significantly higher in the cortex, hippocampus and brain stem. GABA was slightly and not significantly higher in the cortex, hippocampus and brain stem, whereas taurine was significantly higher in all areas except diencephalon and glycine was significantly lower in the diencephalon and cerebellum. In this context, the inability of iNOS(-/-) mice to increase the NO levels following PTZ administrations indicate that NO might play a pro-epileptogenic role in the genesis and development of some types of epilepsy. Since there is no correlation between neurotransmitter levels and the development of kindling, it is possible to exclude that the difference between the two strains is due to an imbalance between the considered neurotransmitters, and it is then possible that this difference is due to the presence of iNOS, which might be involved in long term plasticity of the brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223186     DOI: 10.1016/j.pbb.2006.11.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.

Authors:  M Y Al-Shorbagy; Noha N Nassar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-01       Impact factor: 3.000

2.  A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice.

Authors:  Borna Payandemehr; Mahsima Khoshneviszadeh; Bardia Varastehmoradi; Ramtin Gholizadeh; Taraneh Bahremand; Hossein Attar; Arash Bahremand; Ahmad Reza Dehpour
Journal:  Neurochem Res       Date:  2015-07-28       Impact factor: 3.996

3.  The role for nitric oxide on the effects of hydroalcoholic extract of Achillea wilhelmsii on seizure.

Authors:  Mahmoud Hosseini; Fatemeh Harandizadeh; Saeed Niazmand; Mohammad Soukhtanloo; Azadeh Faizpour; Marzieh Ghasemabady
Journal:  Avicenna J Phytomed       Date:  2014-07

4.  Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy.

Authors:  Carmen De Caro; Antonio Leo; Valentina Nesci; Carla Ghelardini; Lorenzo di Cesare Mannelli; Pasquale Striano; Carmen Avagliano; Antonio Calignano; Paolo Mainardi; Andrew Constanti; Rita Citraro; Giovambattista De Sarro; Emilio Russo
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

5.  Involvement of nNOS, and α1, α2, β1, and β2 Subunits of Soluble Guanylyl Cyclase Genes Expression in Anticonvulsant Effect of Sumatriptan on Pentylenetetrazole-Induced Seizure in Mice.

Authors:  Faiza Mumtaz; Hamed Shafaroodi; Sadaf Nezamoleslami; Muhammad Zubair; Mohammad Sheibani; Vahid Nikoui; Mahmoud Ghazi-Khansari; Ahmad Reza Dehpour
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.